Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries

Journal of Acquired Immune Deficiency Syndromes

Volumn 68, Issue 1, 2015, Pages 62-72

  Koller, Manuel ^a   Patel, Kunjal ^b   Chi, Benjamin C ^c   Wools Kaloustian, Kara ^d   Dicko, Fatoumata ^e   Chokephaibulkit, Kulkanya ^f   Chimbetete, Cleophas ^g   Avila, Dorita ^h   Hazra, Rohan ⁱ   Ayaya, Samual ^j   Leroy, Valeriane ^l   Truong, Huu Khanh ^a   Egger, Matthias ^k   Davies, Mary Ann ^l  

^a UNIVERSITY OF BERN   (Switzerland)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Gabriel Toure Hospital   (Mali)

^f MAHIDOL UNIVERSITY   (Thailand)

^g Newlands Clinic   (Zimbabwe)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

ⁱ MOI UNIVERSITY   (Kenya)

^j INSERM   (France)

^k CHILDREN S HOSPITAL 1   (Viet Nam)

^l UNIVERSITY OF CAPE TOWN   (South Africa)

more..

Author keywords

Antiretroviral; CD4; Children; Global; Immunodeficiency

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; BENIN; BOTSWANA; BRAZIL; BURKINA FASO; CAMBODIA; CD4 LYMPHOCYTE COUNT; CHILD; COTE D'IVOIRE; FEMALE; GHANA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INDONESIA; KENYA; MAJOR CLINICAL STUDY; MALAWI; MALAYSIA; MALE; MALI; MOZAMBIQUE; PERU; RWANDA; SENEGAL; SOUTH AFRICA; TANZANIA; THAILAND; UGANDA; UNITED STATES; VIET NAM; ZAMBIA; ZIMBABWE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; IMMUNOLOGY;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS;

EID: 84919360255     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000380     Document Type: Article

References (38)

1. World Health Organization UNAIDS UNICEF. Global HIV/AIDS Response: Epidemic Update and Health Sector Progress towards Universal Access: Progress Report 2011 2011. Available at: http://www. who.int/hiv/pub/progress-report2011/en/index.html. Accessed June 7, 2012
2. World Health Organization. Global Update on the Health Sector Response to HIV, 2014. Geneva, Switzerland; 2014. Available at: http://www.who.int/hiv/pub/progressreports/en/. Accessed July 21, 2014
3. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888-1899
4. Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477-489
5. Davies MA, Keiser O, Technau K, et al. Outcomes of the south african national antiretroviral treatment programme for children: the IeDEA southern africa collaboration. S Afr Med J. 2009;99:730-737
6. Leroy V, Malateste K, Rabie H, et al. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr. 2013;62:208-219
7. World Health Organization. Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach-2010 revision. 2010;1-194. Available at: http://www.who.int/hiv/pub/paediatric/infants2010/en/index.html. Accessed July 26, 2011
8. Davies M, May M, Bolton-Moore C, et al. Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs. Pediatr Infect Dis J. 2014;33: 608-616
9. World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Summary of Key Features and Recommendations. 2013. Available at: http://www.who.int/hiv/pub/guidelines/arv2013/short-summary/en/index.html. Accessed February 11, 2014
10. Wettstein C, Mugglin C, Egger M, et al. Missed opportunities to prevent mother-to-child-transmission in sub-Saharan africa: systematic review and meta-analysis. AIDS. 2012;26:2361-2373
11. Gange SJ, Kitahata MM, Saag MS, et al. Cohort profile: the North american AIDS cohort collaboration on research and design (NAACCORD). Int J Epidemiol. 2007;36:294-301
12. McGowan CC, Cahn P, Gotuzzo E, et al. Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol. 2007;36:969-976
13. Zhou J, Kumarasamy N, Ditangco R, et al. The TREAT Asia HIV Observational Database: baseline and retrospective data. J Acquir Immune Defic Syndr. 2005;38:174-179
14. The IeDEA Pediatric Working Group. A survey of paediatric HIV programmatic and clinical management practices in Asia and sub-Saharan Africa-The International epidemiologic Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc. 2013;16:17998
15. Hazra R, Stoszek SK, Hance LF, et al. Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries. Int J Epidemiol. 2009;38:1207-1214
16. Van Dyke RB, Patel K, Siberry GK, et al. Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes. J Acquir Immune Defic Syndr. 2011; 57:165-173
17. Patel K, Ming X, Williams PL, et al. International Maternal Pediatric Adolescent ACTCST. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS. 2009;23:1893-1901
18. The World Bank. How we classify countries. Available at: http://data. worldbank.org/about/country-classifications. Accessed December 5, 2012
19. World Health Organization. Antiretroviral therapy for HIV Infection in adults and adolescents in resource-limited settings: towards universal access. Recommendations for a Public Health Approach. 2006. Available at: http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf. Accessed July 27, 2007
20. World Health Organization. Towards universal access. Scaling up priority HIV/AIDS interventions in the health sector. Prog Rep. 2010 2010. Available at: http://www.who.int/hiv/pub/2010progressreport/en/index.html. Accessed May 8, 2012
21. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley; 1987
22. Fatti G, Bock P, Eley B, et al. Temporal trends in baseline characteristics and treatment outcomes of children starting antiretroviral treatment: an analysis in four provinces in South Africa, 2004-2009. J Acquir Immune Defic Syndr. 2011;58:e60-67
23. Peacock-Villada E, Richardson BA, John-Stewart GC. Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countries. Pediatrics. 2011;127:e423-441
24. McNairy ML, Lamb MR, Carter RJ, et al. Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania. J Acquir Immune Defic Syndr. 2013;62:e70-81
25. UNAIDS. 2013 Progress report on the global plan towards the elimination of new HIV infection in children by 2015 and keeping their mothers alive. 2013. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/20130625-progress-global-plan-en.pdf. Accessed June 25, 2013
26. Ferrand R, Lowe S, Whande B, et al. Survey of children accessing HIV services in a high prevalence setting: time for adolescents to count? Bull World Health Organ. 2010;88:428-434
27. Ferrand RA, Munaiwa L, Matsekete J, et al. Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe. Clin Infect Dis. 2010;51:844-851
28. Johnson LF, Boulle A. How should access to antiretroviral treatment be measured? Bull World Health Organ. 2011;89:157-160
29. Chatterjee A, Tripathi S, Gass R, et al. Implementing services for Early Infant Diagnosis (EID) of HIV: a comparative descriptive analysis of national programs in four countries. BMC Public Health. 2011;11:553
30. Sherman GG, Cooper PA, Coovadia AH, et al. Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr Infect Dis J. 2005;24:993-997
31. Yapo V, dAquin Toni T, Desmonde S, et al. Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Cote dIvoire. The Pedi-test DBS ANRS 12183 study. J Virol Methods. 2013;193:439-445
32. Sibanda E, Weller I, Hakim J, et al. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. AIDS. 2013;27:2787-2797
33. Dube Q, Dow A, Chirambo C, et al. Implementing early infant diagnosis of HIV infection at the primary care level: experiences and challenges in Malawi. Bull World Health Organ. 2012;90:699-704
34. Seidenberg P, Nicholson S, Schaefer M, et al. Early infant diagnosis of HIV infection in Zambia through mobile phone texting of blood test results. Bull World Health Organ. 2012;90:348-356
35. Rollins N, Mzolo S, Moodley T, et al. Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings. AIDS. 2009;23:1851-1857
36. Weigel R, Kamthunzi P, Mwansambo C, et al. Effect of providerinitiated testing and counseling and integration of ART services on access to HIV diagnosis and treatment for children in Lilongwe, Malawi: a pre-post comparison. BMC Pediatr. 2009;9:80
37. Mugglin C, Wandeler G, Estill J, et al. Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review. PLoS One. 2013;8:e56446
38. Penazzato M, Davies M, Apollo T, et al. Task shifting for the delivery of pediatric antiretroviral treatment: a systematic review. J Acquir Immune Defic Syndr. 2014;65:414-422